Psychopharmacologic Drugs Advisory Committee Meeting

March 23, 2006†††††††††

 

TABLE OF CONTENTS

 

 

Tab 1:†††††††† FDA Cover Memo - Laughren

 

Tab 2:†††††††† FDA Clinical Review - Mannheim

 

Tab 3:†††††††† FDA Statistical Review - Massie

 

Tab 4:†††††††† FDA Approvable Letter - Andreason

 

Tab 5:†††††††† FDA Approvable Letter - Laughren

 

Tab 6:†††††††† FDA Approvable Letter

 

Tab 7:†††††††† FDA Dermatology Consult - Luke

 

Tab 8:†††††††† FDA Dermatology Consult - Porres

 

Tab 9:†††††††† Sponsorís Proposed Label